Case report demonstrates dupilumab efficacy in achieving long-term remission in severe eosinophilic pustular folliculitis, suggesting a new treatment option.
Dupilumab demonstrated significant efficacy and safety in this severe and refractory EPF case, resulting in long-term remission without relapse, and highlighting its potential as a novel treatment option for EPF.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: